![Reza Halse](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Reza Halse
Presidente presso
RA Capital Management LP (Private Equity)
Profilo
Reza Halse currently works at Summation Bio, Inc., as Director, CinRx Pharma LLC, as President from 2026, MRL Ventures Fund LLC, as President, Partners Research Ventures & Licensing, as Partner, Droia Ventures, as Partner, and RA Capital Management LP (Private Equity), as President from 2021.
Dr. Halse also formerly worked at TargAnox, Inc., as Chief Executive Officer from 2014 to 2015, Genome Canada, as Chairman from 2013 to 2016, Visterra, Inc., as Director, Novartis Pharmaceuticals, as Associate Director from 2004 to 2008, IOmet Pharma Ltd., as Director, Spero Therapeutics, Inc., as Director, Alector, Inc., as Director, Raze Therapeutics, Inc., as Director, BioMed Valley Discoveries, Inc., as Director from 2008 to 2011, Biocom, Inc., as Member-Governors Board, Partners HealthCare Corp., as Partner from 2012 to 2015, Xcellsyz Ltd., as Head-Cell Biology, Merck Research Ventures, as President from 2017 to 2021, and LAVA Therapeutics NV, as Member-Supervisory Board.
Dr. Halse received his undergraduate degree and doctorate degree from The University of Newcastle.
Posizioni attive di Reza Halse
| Società | Posizione | Inizio |
|---|---|---|
Partners Research Ventures & Licensing
 Partners Research Ventures & Licensing Miscellaneous Commercial ServicesCommercial Services Provides management services | Corporate Officer/Principal | - |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Presidente | 01/03/2021 |
Summation Bio, Inc.
 Summation Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops a novel non-viral gene transfer technology | Direttore/Membro del Consiglio | - |
DROIA NV
 DROIA NV Investment ManagersFinance Droia Ventures invests in companies located across the globe. The firm focuses on oncology and gentic disease related drug development companies. It provides financing for seed and early stage capital requirements. | Investitore di Private Equity | - |
MRL Ventures Fund LLC
 MRL Ventures Fund LLC Investment ManagersFinance Operates as a venture capital fund | Presidente | - |
CinRx Pharma LLC
 CinRx Pharma LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company that develops medicines | Presidente | 10/02/2026 |
Precedenti posizioni note di Reza Halse
| Società | Posizione | Fine |
|---|---|---|
Merck Research Ventures
 Merck Research Ventures Investment ManagersFinance Merck Research invests in companies located globally. The firm targets companies operating in the therapeutics sector. It participates in seed and early stage capital requirements with an investment size of up to USD 25 million. The firm acts as a lead and co-lead investor and takes a seat on the board of directors. It also makes follow-on investments and does not invest in medical devices, diagnostic platforms and digital health. | Presidente | 31/03/2021 |
IOmet Pharma Ltd.
 IOmet Pharma Ltd. Drugstore ChainsRetail Trade Develops drugs and related products | Direttore/Membro del Consiglio | 21/06/2018 |
Genome Canada
 Genome Canada Miscellaneous Commercial ServicesCommercial Services Provides genomic research services | Presidente | 30/06/2016 |
| ░░░░░░░░ ░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Reza Halse
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
10
Relazioni di 1° grado
21
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 21 |
|---|---|
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
TargAnox, Inc.
 TargAnox, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to prevent oxidative stress diseases | Health Technology |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services | Commercial Services |
The University of Newcastle
 The University of Newcastle Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Partners HealthCare Corp.
 Partners HealthCare Corp. Hospital/Nursing ManagementHealth Services Provides patient care, research, teaching and community services | Health Services |
Genome Canada
Genome Canada Miscellaneous Commercial ServicesCommercial Services Provides genomic research services | Commercial Services |
Novartis Pharmaceuticals
 Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Xcellsyz Ltd.
 Xcellsyz Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that focuses on discovery of drugs | Commercial Services |
Partners Research Ventures & Licensing
Partners Research Ventures & Licensing Miscellaneous Commercial ServicesCommercial Services Provides management services | Commercial Services |
IOmet Pharma Ltd.
IOmet Pharma Ltd. Drugstore ChainsRetail Trade Develops drugs and related products | Retail Trade |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Alector, Inc.
 Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
Raze Therapeutics, Inc.
 Raze Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops oncology therapeutics | Health Technology |
DROIA NV
DROIA NV Investment ManagersFinance Droia Ventures invests in companies located across the globe. The firm focuses on oncology and gentic disease related drug development companies. It provides financing for seed and early stage capital requirements. | Finance |
Merck Research Ventures
Merck Research Ventures Investment ManagersFinance Merck Research invests in companies located globally. The firm targets companies operating in the therapeutics sector. It participates in seed and early stage capital requirements with an investment size of up to USD 25 million. The firm acts as a lead and co-lead investor and takes a seat on the board of directors. It also makes follow-on investments and does not invest in medical devices, diagnostic platforms and digital health. | Finance |
CinRx Pharma LLC
CinRx Pharma LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company that develops medicines | Commercial Services |
MRL Ventures Fund LLC
MRL Ventures Fund LLC Investment ManagersFinance Operates as a venture capital fund | Finance |
BioMed Valley Discoveries, Inc.
 BioMed Valley Discoveries, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops therapies for cancer, inflammation and infectious disease | Commercial Services |
LAVA Therapeutics NV
 LAVA Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops antibodies for the treatment of cancer | Health Technology |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Finance |
Summation Bio, Inc.
Summation Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops a novel non-viral gene transfer technology | Commercial Services |
